Cargando…
The heart in rheumatic, autoimmune and inflammatory diseases : pathophysiology, clinical aspects and therapeutic approaches /
This book examines the complex mechanisms of autoimmune rheumatic conditions relating to cardiac diseases from a pathophysiological and clinical point of view. It addresses the increased risk that advanced atherosclerosis plays and its pivotal role in the development of cardiac diseases in systemic,...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
London, United Kingdom :
Academic Press is an imprint of Elsevier,
2017.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000Ii 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_ocn972734332 | ||
| 003 | OCoLC | ||
| 005 | 20231120112212.0 | ||
| 006 | m o d | ||
| 007 | cr cnu|||unuuu | ||
| 008 | 170216s2017 enk ob 001 0 eng d | ||
| 010 | |a 2015949203 | ||
| 040 | |a N$T |b eng |e rda |e pn |c N$T |d OPELS |d EBLCP |d N$T |d YDX |d IDEBK |d UPM |d MERER |d OCLCQ |d OCLCO |d OTZ |d OCLCQ |d CASUM |d OCLCQ |d OCLCO |d OCLCQ |d OCLCO |d OCLCQ |d GGVRL |d D6H |d U3W |d OCLCF |d OCLCO |d WYU |d OCLCO |d OCLCA |d OCLCQ |d SDF |d LVT |d VT2 |d OCLCO |d OCLCQ |d SFB |d OCLCO | ||
| 066 | |c (S | ||
| 019 | |a 972603011 |a 972828138 |a 973002623 |a 973083382 |a 973301031 |a 973381871 |a 973530202 |a 973760042 |a 1066464636 |a 1229456878 |a 1235840532 | ||
| 020 | |a 9780128032688 |q (electronic bk.) | ||
| 020 | |a 0128032685 |q (electronic bk.) | ||
| 020 | |z 9780128032671 |q (print) | ||
| 020 | |z 0128032677 | ||
| 035 | |a (OCoLC)972734332 |z (OCoLC)972603011 |z (OCoLC)972828138 |z (OCoLC)973002623 |z (OCoLC)973083382 |z (OCoLC)973301031 |z (OCoLC)973381871 |z (OCoLC)973530202 |z (OCoLC)973760042 |z (OCoLC)1066464636 |z (OCoLC)1229456878 |z (OCoLC)1235840532 | ||
| 050 | 4 | |a RC682 | |
| 060 | 4 | |a WG 210 | |
| 060 | 4 | |a 2017 E-541 | |
| 072 | 7 | |a HEA |x 039000 |2 bisacsh | |
| 072 | 7 | |a MED |x 014000 |2 bisacsh | |
| 072 | 7 | |a MED |x 022000 |2 bisacsh | |
| 072 | 7 | |a MED |x 112000 |2 bisacsh | |
| 072 | 7 | |a MED |x 045000 |2 bisacsh | |
| 082 | 0 | 4 | |a 616.1/2 |2 23 |
| 245 | 0 | 4 | |a The heart in rheumatic, autoimmune and inflammatory diseases : |b pathophysiology, clinical aspects and therapeutic approaches / |c edited by Udi Nussinovitch. |
| 264 | 1 | |a London, United Kingdom : |b Academic Press is an imprint of Elsevier, |c 2017. | |
| 300 | |a 1 online resource | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 500 | |a Includes index. | ||
| 588 | 0 | |a Online resource; title from PDF title page (ScienceDirect, viewed February 23, 2017). | |
| 505 | 0 | |6 880-01 |a Front Cover; THE HEART IN RHEUMATIC, AUTOIMMUNEAND INFLAMMATORY DISEASES; Dedication; THE HEART IN RHEUMATIC, AUTOIMMUNE ANDINFLAMMATORY DISEASES: PATHOPHYSIOLOGY, CLINICAL ASPECTS; Copyright; Contents; List of Contributors; About the Editor; Preface; Acknowledgments; I -- IMMUNE MEDICATED CARDIAC INJURY, ACCELERATED ATHEROSCLEROSIS ANDTHE STUDY OF CARDIAC INVOLVEMENTS IN SYSTEMIC DISEASES; 1 -- Pathophysiology of Autoimmunity and Immune-Mediated Mechanisms in Cardiovascular Diseases; 1. PATHOPHYSIOLOGY OF AUTOIMMUNITY; 1.1 Etiology of Autoimmunity; 1.1.1 Environmental Factors. | |
| 505 | 8 | |a 1.1.2 Infectious Agents1.1.3 Hormonal Associations; 1.1.4 Psychological Effectors; 1.2 Complement System and Autoimmunity; 1.2.1 Complement Compound Deficiency and Autoimmunity; 1.2.2 Impaired Function of Regulatory Proteins of the Complement System; 1.2.2.1 CD55; 1.2.2.2 CD59; 1.2.2.3 CD46; 1.2.2.4 Crry; 1.2.2.5 C1-INH; 1.3 Autoantibodies and Autoantigens; 1.4 T helper Balance and Autoimmunity; 1.5 Diagnostic Criteria for Immune-Mediated Diseases; 2. IMMUNE-MEDIATED MECHANISMS OF CARDIOVASCULAR DISEASES; 2.1 Systemic Inflammation and the Vascular Wall. | |
| 505 | 8 | |a 2.1 Pathogenesis of Organ-Specific Autoimmune Myocarditis/Inflammatory Cardiomyopathy3. CLINICAL PRESENTATION AND DIAGNOSIS OF MYOCARDITIS; 3.1 Electrocardiography (ECG) and Echocardiography; 3.2 Nuclear Techniques and Cardiovascular Magnetic Resonance Imaging; 3.3 Clinically Suspected Myocarditis: 2013 ESC Task Force Criteria; 3.4 Definite (Biopsy-Proven) Myocarditis: 2013 ESC Task Force Criteria; 3.5 Inflammatory Diagnostic Markers; 3.6 Troponins and Natriuretic Peptides; 3.7 Viral Serology; 3.8 Serum Cardiac Autoantibodies (AABs): Diagnostic and Clinical Relevance; 4. SPECIFIC AABS TESTS. | |
| 520 | |a This book examines the complex mechanisms of autoimmune rheumatic conditions relating to cardiac diseases from a pathophysiological and clinical point of view. It addresses the increased risk that advanced atherosclerosis plays and its pivotal role in the development of cardiac diseases in systemic, rheumatic and autoimmune illnesses. | ||
| 504 | |a Includes bibliographical references and index. | ||
| 650 | 0 | |a Heart |x Diseases. | |
| 650 | 0 | |a Rheumatism |x Complications. | |
| 650 | 0 | |a Autoimmune diseases |x Complications. | |
| 650 | 0 | |a Inflammation |x Complications. | |
| 650 | 2 | |a Heart Diseases |x physiopathology |0 (DNLM)D006331Q000503 | |
| 650 | 2 | |a Heart Diseases |0 (DNLM)D006331 | |
| 650 | 6 | |a C�ur |x Maladies. |0 (CaQQLa)201-0005230 | |
| 650 | 6 | |a Rhumatisme |0 (CaQQLa)201-0006739 |x Complications et s�equelles. |0 (CaQQLa)201-0374854 | |
| 650 | 6 | |a Maladies auto-immunes |0 (CaQQLa)201-0064242 |x Complications et s�equelles. |0 (CaQQLa)201-0374854 | |
| 650 | 6 | |a Inflammation (Pathologie) |0 (CaQQLa)201-0026988 |x Complications et s�equelles. |0 (CaQQLa)201-0374854 | |
| 650 | 7 | |a HEALTH & FITNESS |x Diseases |x General. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Clinical Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Diseases. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Evidence-Based Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Internal Medicine. |2 bisacsh | |
| 650 | 7 | |a Heart |x Diseases |2 fast |0 (OCoLC)fst00953527 | |
| 650 | 7 | |a Rheumatism |x Complications |2 fast |0 (OCoLC)fst01097005 | |
| 655 | 0 | |a Electronic book. | |
| 655 | 4 | |a Internet Resources. | |
| 700 | 1 | |a Nussinovitch, Udi, |e editor. | |
| 776 | 0 | 8 | |i Print version: |t Heart in rheumatic, autoimmune and inflammatory diseases. |d London, United Kingdom : Academic Press is an imprint of Elsevier, 2017 |z 9780128032671 |z 0128032677 |w (OCoLC)957503451 |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9780128032671 |z Texto completo |
| 880 | 8 | |6 505-00/(S |a 2.2 Pro- and Anti-inflammatory Cytokines Balance and Cardiovascular Diseases2.2.1 Anti-inflammatory Cytokines; 2.2.1.1 IL-4; 2.2.1.2 IL-10; 2.2.1.3 IL-11; 2.2.1.4 IL-13; 2.2.1.5 TGF-β; 2.2.2 Proinflammatory Cytokines; 2.2.2.1 TNF-α; 2.2.2.2 IL-1; 2.2.2.3 IL-6; 2.2.2.4 IL-17; 3. CONCLUSIONS; References; 2 -- Organ-Specific Autoimmune Myocardial Diseases: From Pathogenesis to Diagnosis and Management; 1. INTRODUCTION; 1.1 Definition of Organ-Specific Autoimmune Disease; 1.2 Definitions of Myocarditis and of Inflammatory Cardiomyopathy; 2. AETIOPATHOGENESIS OF MYOCARDITIS. | |
| 880 | 8 | |6 505-01/(S |a 4.1 Anti-heart AABs and Anti-intercalated Disk AABs by Standard Indirect Immunofluorescence (Fig. 2.4)4.1.1 Clinical and Prognostic Significance of AHA in Symptom-Free Subjects; 4.2 AABs to Myosin Heavy Chain; 4.3 AABs to β-adrenergic and M2-Muscarinic Receptors; 4.4 Cardiodepressant AABs; 4.5 AABs to Other Sarcolemmal Autoantigens and Heat Shock Proteins; 4.6 AABs to Mitochondrial Antigens; 5. NATURAL HISTORY AND PROGNOSTIC FACTORS OF BIOPSY-PROVEN MYOCARDITIS; 6. SPECIFIC FORMS OF IMMUNE-MEDIATED MYOCARDITIS; 6.1 Chagas Myocarditis. | |